Computational Chemist, Target Druggability and Structure-Based Design
Schrödinger · New York; Cambridge, MA; San Diego; Portland, Cambridge, New York +2 · Posted Oct 27, 2026
Transparency
StaleOnline for 3 weeks and never reposted. The first wave of applicants is in, so a reply is less likely. Apply if it's a strong fit.
- First seen
- Oct 28, 2026
- Offered for
- 24 days
Overview
- Category
- Science
- Employment type
- Permanent
- Workplace type
- On-site
- Country
- United States
- Seniority
- Associate
- Schedule
- Full time
- Salary
- Not listed
Key skills
- Structure‑Based Drug Design
- Design and optimize ligands using protein structures and computational modeling.
- Molecular Modeling
- Apply molecular simulations to evaluate binding modes and guide lead optimization.
- Cryptic Pocket Identification
- Detect transient binding sites on proteins through computational and experimental methods.
- Target Tractability Assessment
- Integrate structural, computational, biophysical and biological data to evaluate druggability.
- Virtual Ligand Screening
- Perform large‑scale in‑silico screening to prioritize candidate molecules.
- Generative Structure Prediction
- Use AI‑driven tools to predict novel protein conformations for drug discovery.
Key phrases
- molecular modelling
- structural biology
- virtual ligand screening
- generative structure prediction
- cryptic pocket identification
- alternative conformations
- transient binding sites
- software development teams
- Schrödinger’s drug discovery technologies
- interdisciplinary environments
From the posting
Schrödinger seeks a Computational Chemist (Target Druggability and Structure-Based Drug Design) to join us in our mission to transform the discovery of therapeutics!
As a member of the Schrödinger Therapeutics Group (STG), you’ll join a team of over 60 scientists that includes designers, modelers, computational chemists, medicinal chemists, crystallographers, biochemists, and biologists with experience working on all common target classes and therapeutic areas. The group is supported by more than 100 software developers and engineers, as well as a large-scale computer infrastructure.
Who will love this job:
- A structure-based drug designer with deep training in molecular modelling, with an emphasis on the following areas: structural biology, computationally-driven lead optimization, virtual ligand screening, generative structure prediction, or cryptic pocket identification.
- A scientist trained cross-functionally, with experience in both computational chemistry and experimental structural biology or experimental hit-finding environments
- A team player who enjoys working in interdisciplinary environments and has excellent communication skills
What you’ll do:
- Support active drug discovery projects as a computational chemist/modeler
- Contribute to new-target selection by integrating structural, computational, biophysical, and biological evidence into concise target-tractability assessments, identifying key uncertainties and proposing experiments or calculations that could resolve them.
- Partner with cross-functional experts to develop strategies for promising targets, including approaches to investigate alternative conformations or potential transient binding sites.
- Work closely with the internal software development teams to improve Schrödinger’s drug discovery technologies.
- Share knowledge with the greater Schrödinger Therapeutic Group (STG)
What you should have:
- PhD in Computational Chemistry, Structural Biology, or a related discipline
- Experience in structure-based drug design and the ability to critically interpret protein structures in the context of ligand binding, drawing on modern computational and experimental approaches for structure prediction and cryptic pocket identification
- Postdoctoral experience and/or at least one year of industry experience preferred
